期刊文献+

卡马西平、左乙拉西坦对伴中央-颞区棘波的小儿良性癫痫患儿认知功能的影响 被引量:10

下载PDF
导出
摘要 目的观察左乙拉西坦对伴中央-颞区棘波的小儿良性癫痫患儿认知功能的影响。方法符合诊断标准的癫痫儿童80例随机分为2组,卡马西平组(40例)用卡马西平治疗,左乙拉西坦组(40例)用左乙拉西坦治疗,治疗12周。治疗前后分别测定患儿智商,分析2组儿童治疗前后认知功能的变化。结果治疗前后2组儿童语言智商(VIQ)、操作智商(PIQ)和总智商(FIQ)差异无统计学意义(P>0.05)。但左乙拉西坦组知识、算术、词汇、图形拼凑五项得分高于卡马西平组(P<0.05);卡马西平组治疗前后VIQ、PIQ和FIQ差异无统计学意义(P>0.05),而治疗后木块图案、图形拼凑得分降低(P<0.05);左乙拉西坦组治疗前后VIQ、PIQ和FIQ差异无统计学意义(P>0.05),而治疗后知识、算术、词汇、图形拼凑得分增加(P<0.05)。结论左乙拉西坦对伴中央-颞区棘波的小儿良性癫痫患儿认知功能无影响并可改善患儿的认知功能。
出处 《河北医药》 CAS 2009年第10期1195-1196,共2页 Hebei Medical Journal
  • 相关文献

参考文献7

  • 1Wirrell EC.Benign epilepsy of childhood with centro-temporal spikes.Epilepsia,1998,39:S32-S41. 被引量:1
  • 2吴希如,林庆主编..小儿神经系统疾病基础与临床[M].北京:人民卫生出版社,2000:744.
  • 3林传鼎,张厚粲主编.韦氏儿童智力量表中国修订本(WISC-CR).第1版.北京:北京师范大学出版社,1986.120. 被引量:1
  • 4Aldenkamp AP,de Krom M,Reijs R.Newer an tipe ileptic drugs and cognitive issuse.Epilepsia,2003,44(suppl4):S21-S29. 被引量:1
  • 5Lagae L.Cognitive side effects of anti-epileptic drugs Therelevance in childhood epilepsy.Seizure,2006,15:235-241. 被引量:1
  • 6李淑敏,施荣富,王克玲,张凤珍.左乙拉西坦单药治疗伴中央-颞区棘波的小儿良性癫痫近期疗效观察[J].河北医药,2008,30(9):1382-1382. 被引量:14
  • 7Piazzini A,Chifari R,Canevini MP,et al.Levetiracetam:an improvement of attention and of oral fluency in patients with partial epilepsy.Epilepsy Res,2006,68:181. 被引量:1

二级参考文献8

  • 1Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology, 2006,66:1654-1660. 被引量:1
  • 2Zona C, Niespodziany I, Marchettic M, et al. Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca^2+ currents. Seizures, 2001, 10: 279-286. 被引量:1
  • 3Rigo JM, Hans G, Nguyen L, et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA and glycine-gated currents. Br J Pharmacol,2002,136:659-672. 被引量:1
  • 4Lynch BA,Lambeng N,Nocka K, et al,The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA,2004,101:9861-9866. 被引量:1
  • 5Growder KM, Gunther JM, Jones TA, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci USA, 1999,96 : 15268-15273. 被引量:1
  • 6Ben-Menachem E, Edrich P, Van Vleymen B, et al. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res,2003,53 : 57-64. 被引量:1
  • 7Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double blind, responder selected study evaluating monotherapy European Levetiracetam Study Group. Epilepsia, 2000,41 : 1276-1253. 被引量:1
  • 8Welty TE, Gidal BE, Ficker DM, et al. Levetiracetam : a different approach to the phannacotherapy of epilepsy. Ann Phannacother, 2002,36: 296-304. 被引量:1

共引文献13

同被引文献118

引证文献10

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部